AgeX Therapeutics, Inc. (commonly abbreviated as AgeX Therapeutics or simply AgeX) is an American biotechnology company developing medical therapeutics...

De Grey was formerly Vice President of New Technology Discovery at AgeX Therapeutics, a startup in the longevity space helmed by Michael D. West. He was...

a series of corporate transactions including the distribution of AgeX Therapeutics, the acquisition of Asterias Biotherapeutics and conducting management...

biogerontologist, and a pioneer in stem cells, cellular aging and telomerase. He is the founder and CEO of AgeX Therapeutics, a startup focused on the field of experimental...

lifespan and healthspan in humans. 2017 AgeX Therapeutics, a biotechnology company focused on medical therapeutics related to longevity, was founded. 2018...

Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development...

founded by gerontologist Mary C. West and Michael D. West, now CEO of AgeX Therapeutics. They secured initial venture capital investments in the company from...

premature aging. In the mid-1990s, Greider was recruited by Michael D. West, founder of biotechnology company Geron (now CEO of AgeX Therapeutics) to join...

RNA therapeutics are a new class of medications based on ribonucleic acid (RNA). Research has been working on clinical use since the 1990s, with significant...

in a periodical called Anti-Aging Therapeutics, this is edited by Klatz and Goldman. The International Journal of Anti-Aging Medicine (IJAAM) was another...